National Guidance, Supporting Policies and Contractual Frameworks

National Guidance - 

The NICE guideline on Familial hypercholesterolaemia: identification and management covers identifying and managing familial hypercholesterolaemia (FH) and aims to help identify people at increased risk of coronary heart disease as a result of having FH.

Contractual Frameworks - 

The NHS Long Term Plan commits to increasing the diagnosis of familial hypercholesterolaemia from 7% to 25% by 2024/25. Early detection and genetic diagnosis to enable early intervention will reduce risk and enable better outcomes for FH patients. 

You can read more about FH inclusion in the PCN Network Contracted DES and the Investment and Impact Fund here.